Meteora Capital »

Carmell Therapeutics Corp - US shares owned by Meteora Capital

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Meteora Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.4M 1.8M 3.60

More positions owned by Meteora Capital

Churchill Capital Corp Vii Com Cl A (CVII)
Altc Acquisition Corp Com Cl A (ALCC)
Ares Acquisition Corporation Com Cl A
Graf Acquisition Corp Iv
Churchill Capital Corp Vi Com Cl A
Roadzen Ord Shs (RDZN)
L Catterton Asia Acquisition Class A Ord Shs
Churchill Capital Corp V Com Cl A
Zalatoris Acquisition Corp Com Cl A (TCOA)
Viveon Health Acquisition Common Stock (VHAQ)
Pyrophyte Acquisition Corp Cl A Ord Shs (PHYT)
Slam Corp Cl A Shs (SLAM)
Flame Acquisition Corp Com Cl A
Leo Hldgs Corp Ii Com Cl A
Ocean Biomedical (OCEA)

View all positions for Meteora Capital

Top funds holding Carmell Therapeutics Corp - US

Vanguard Group
Carnegie Mellon University
Citadel Advisors
Hubbell Strickland Wealth Management
UBS Group
Wells Fargo & Company
Royal Bank of Canada
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Carmell Therapeutics Corp - US